Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-21

Clinical Trial Update: Subcutaneous Dexpanthenol Administration and Wound Epithelialization [NA]

View source ↗

Summary

This clinical trial update covers subcutaneous dexpanthenol to promote wound epithelialization in chronic wounds, including diabetic foot ulcers, venous leg ulc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexpanthenol (dexpanthenol)

Snippet

Sponsor: Dilara CANBAY OZDEMIR | Conditions: Chronic Wounds, Diabetic Foot Ulcer | NA | Status: NOT_YET_RECRUITING